Precision Driven Health announces sponsorship of Hack Aotearoa 2020
- : Precision Driven Health
- : 09/01/2020
Precision Driven Health (PDH) is excited to return in 2020 as a major partner for Hack Aotearoa.
Building on the success of the 2019 conference – the first of its kind in New Zealand – Hack Aotearoa 2020 continues to innovate and will include a health datathon in addition to the main Artificial Intelligence in Healthcare conference.
This globally recognised Massachusetts Institute of Technology (MIT) Critical Data event aims to spark cross-disciplinary collaboration and learning of data science to improve healthcare. Hosted by the University of Auckland’s Faculty of Medical and Health Sciences and Massachusetts Institute of Technology (MIT) Critical Data, the event will see local and international data scientists, academics and healthcare professionals come together to present opportunities for the use of data science and Artificial Intelligence (AI) in health.
The overarching theme for the 2020 event is ‘Advancing the Quadruple Aim’, while the ethical use of data, and the use of data for Māori health equity, are key event themes. Hack Aotearoa is an exciting opportunity to advance the digital health and data science landscape in Aotearoa.
During the datathon, healthcare professionals and data scientists will have the chance to work with the MIT eICU Collaborative Care and MIMIC Critical Care datasets. The aim is to harness insights from these datasets and search for better ways to diagnose and treat critical care patients.
Precision Driven Health returns as a major partner for the second year running. Chief Executive Dr Kevin Ross is looking forward to the event.
“As New Zealand’s premier health data science collaboration, we are looking forward to another gathering that looks to unlock the value of data for our population. Hack Aotearoa combines local expertise and values with international know-how to bring a unique, hands-on experience over a few days,” says Dr Ross.
Philips ANZ is another major partner of Hack Aotearoa. As a leading health technology company, Philips ANZ provides connected care solutions powered by advanced analytics in order to improve health outcomes and the delivery of care. At the crux of transitioning towards value-based healthcare, the measurement of system-wide health outcomes and the improvement of patient care delivery is based on a combination of multiple datasets.
“As the owner of the largest translational ICU dataset in the world composed of 7.5 million ICU episodes, Philips is proud to contribute to events like Hack Aotearoa in order to drive academic and practical insights for New Zealand. We need to look at new, more efficient ways to increase access to care and improve care collaboration. Philips believes Hack Aotearoa is a great setting to start those conversations,” says Joe Cain, Business Manager Population Health, Philips ANZ.
Hack Aotearoa will take place 17th to 19th January 2020 at the Owen G Glenn Building, University of Auckland.
About MIT Critical Data
MIT Critical Data is an affiliation of research labs at Massachusetts Institute of Technology (MIT) who are engaged in research in and around data that has a critical impact on people’s health.About Precision Driven Health
The Precision Driven Health partnership (PDH), established in 2016, is one of the most ambitious data science research initiatives to be undertaken in New Zealand. The partnership unites the health IT sector with healthcare providers and universities to create health and commercial opportunities for New Zealanders. Research is focused on applying new data science techniques to understand the massive volume of data about an individual captured by health information systems, consumer devices, social networks, genetic testing and other sources. To date, PDH has supported more than 75 projects in health data science, including summer and postgraduate scholarships, a joint PDH-HRC Postdoctoral Fellowship scheme, and multi-million dollar discovery and transformation programmes in several areas, including de-identification and deep learning. PDH researchers are also exploring vital concepts such as bias in machine learning, the ethics of AI use, and consent paradigms for enabling the next wave of health data research. Find out more at www.precisiondrivenhealth.com.- : Nicole Gray
- : Communications Specialist
- : nicole@precisiondrivenhealth.com
- : 0212290811
- : https://precisiondrivenhealth.com/
- https://twitter.com/HealthPrecision | https://www.linkedin.com/company/15212839/
Precision Driven Health partners with MoleMap in AI project to improve skin cancer detection
- : Precision Driven Health
- : 18/11/2019
Precision Driven Health (PDH), New Zealand’s leading health data research initiative, has today announced it is working with MoleMap on its use of Artificial Intelligence (AI) to improve the early detection of skin cancer.
PDH Chief Executive Dr Kevin Ross says the $2 million research project will enhance the AI algorithm that MoleMap has developed to differentiate cancerous skin lesions from benign lesions.
“Every year nearly 400 New Zealanders die from skin cancer and studies indicate that early detection could have greatly improved the chance of survival in the majority of cases,” Dr Ross says.
“This project has the potential to increase access to skin checks by extending the technology for use at the primary care and general practitioner level, and thereby enabling more New Zealanders access to early detection for skin cancer.”
MoleMap Chief Technology Officer Adrian Bowling says the PDH partnership builds on initial research developed with IBM Research in Melbourne on a small subset of data.
“The partnership with PDH will provide us with access to a larger, wider set of data as we continue to work with experts at the University of Otago in Dunedin, and Monash University in Melbourne, to enhance this ground-breaking technology,” Mr Bowling says.
Computer-based systems for recognising malignant moles have been developed over the past 20 years but have had limited uptake. With the advent of AI, combined with large databases and “deep learning” algorithms, new opportunities for the use of these technologies can be explored.
“Published studies and our own research suggest that it is possible for a system-based AI to be at least as good as dermatologists in differentiating cancerous lesions from benign lesions,” Mr Bowling says.
The research project will include clinical trials in New Zealand and Australia once the algorithm has been enhanced. As essential part of the research is to ensure that the unique population of Aotearoa is taken into account and all skin types will be tested.
Dr Ross says that, as with all PDH projects, a key focus is applying new techniques in data science to advance Māori health outcomes.
“Māori do not have a high incidence of melanoma; however, there is a high mortality rate for those who have melanoma. This has generally been seen as a result of Māori, like many other New Zealanders, presenting with later stage melanoma when it is difficult to cure. Being able to better detect melanoma in Māori could help decrease this mortality risk and save lives.”
For more information and/or an interview with Dr Kevin Ross, contact:
Nicole Gray
Communications Specialist
nicole@precisiondrivenhealth.comAbout Precision Driven Health
The Precision Driven Health partnership (PDH), established in March 2016, is one of the most ambitious data science research initiatives to be undertaken in New Zealand. The partnership unites the health IT sector with health providers and universities to create health and commercial opportunities for New Zealanders. Research is focused on applying new data science techniques to understand the massive volume of data about an individual captured by health information systems, consumer devices, social networks, genetic testing, and other sources. Visit our website precisiondrivenhealth.com.About MoleMap
MoleMap’s team of leading dermatologists and melanographers have been detecting and diagnosing melanoma for over two decades, using a unique skin mapping system that’s designed to track changes in the skin over time. MoleMap has over 40 clinics around New Zealand serving over 250,000 patients nationwide. Visit our website www.molemap.co.nz.- : Nicole Gray
- : Communications Specialist
- : nicole@precisiondrivenhealth.com
- : 0276177235
- https://twitter.com/HealthPrecision | https://www.linkedin.com/company/precision-driven-health/